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Abstract
Background: The interaction of megakaryocytes with matrix proteins of the osteoblastic and vascular niche is essential for
megakaryocyte maturation and proplatelet formation. Fibrinogen is present in the vascular niche and the fibrinogen
receptor aIIbb3 is abundantly expressed on megakaryocytes, however the role of the interaction between fibrinogen and
aIIbb3 in proplatelet formation in humans is not yet fully understood. We have recently reported a novel congenital
macrothrombocytopenia associated with a heterozygous mutation of the b3 subunit of aIIbb3. The origin of
thrombocytopenia in this condition remains unclear and this may represent an interesting natural model to get further
insight into the role of the megakaryocyte fibrinogen receptor in megakaryopoiesis.
Methodology/Principal Findings: Patients’ peripheral blood CD45+ cells in culture were differentiated into primary
megakaryocytes and their maturation, spreading on different extracellular matrix proteins, and proplatelet formation were
analyzed. Megakaryocyte maturation was normal but proplatelet formation was severely impaired, with tips decreased in
number and larger in size than those of controls. Moreover, megakaryocyte spreading on fibrinogen was abnormal, with
50% of spread cells showing disordered actin distribution and more evident focal adhesion points than stress fibres. Integrin
aIIbb3 expression was reduced but the receptor was constitutively activated and a sustained, and substrate-independent,
activation of proteins of the outside-in signalling was observed. In addition, platelet maturation from preplatelets was
impaired.
Conclusions/Significance: Our data show that constitutive activation of aIIbb3-mediated outside-in signalling in human
megakaryocytes negatively influences proplatelet formation, leading to macrothombocytopenia.
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Introduction
Mature megakaryocytes (Mks) migrate to the vascular niche of
the bone marrow where they convert the bulk of their cytoplasm
into multiple long processes, called proplatelets, that protrude
through the vascular endothelium into the sinusoid lumen to
release platelets [1,2]. Recently a new intermediate stage in
platelet maturation has been described: preplatelets, discoid
particles circulating in blood, larger than platelets, that reversibly
convert into barbell-shaped proplatelets that in turn generate each
two mature platelets after a fission event [3].
Very little is known about the role of specific bone marrow
proteins in megakaryocyte differentiation and function. Fibrinogen
was shown to be localized in the bone marrow sinusoids of mice
and to be essential for proplatelet formation by binding to
megakaryocyte aIIbb3 [4]. In fact, mouse megakaryocytes extend
proplatelets when plated on fibrinogen, and treatment with aIIbb3
antagonists strikingly reduces the percentage of megakaryocytes
developing proplatelets [4]. However, the interaction between
integrin aIIbb3 and fibrinogen was shown to be essential for
spreading but not for proplatelet formation by human megakar-
yocytes, and in fact while aIIbb3 antagonists almost abolished
adhesion and spreading they did not cause any significant
reduction of human proplatelet formation [5]. Indeed, Glanzmann
Thrombasthenia (GT), a rare hereditary autosomal recessive
bleeding disorder affecting the megakaryocytic lineage and due to
quantitative and/or qualitative abnormalities of aIIbb3, is not
associated with thrombocytopenia [6]. Therefore, the role of
aIIbb3 in proplatelet formation in humans is still controversial.
We have recently described two families with a novel autosomal
dominant hereditary mucocutaneous bleeding disorder with
macrothrombocytopenia and defective platelet function associated
with a heterozygous mutation (2134+1G .C) of the ITGB3 gene,
coding for the b3 subunit of aIIbb3 and producing a deletion
(del647-686) of a large part of the b Tail Domain (bTD) [7], an
extracellular domain of b3 involved in receptor activation [8]. This
mutation, and in particular a mutation involving the b3 bTD
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it was associated with a reduced platelet number and altered
platelet morphology.
Purpose of the present study was to analyse megakaryocyte
maturation, spreading and proplatelet formation on fibrinogen,
and other extracellular matrix proteins, in two patients with the
Glanzmann variant macrothrombocytopenia associated with the
b3 del647-686.
Results
Megakaryocyte differentiation and proplatelet formation
The percentage of CD45+ cells differentiated into megakaryo-
cytes was comparable in patients and controls (761.8% vs
9.962.7%, respectively, p=ns). Megakaryocyte maturation pro-
files, classified according to standard criteria [9], were not
significantly different between patients and controls, indicating
that del647-686 of a ˆ3 integrin does not affect the differentiation or
maturation of megakaryocytes (Figure 1A).
Proplatelets formed by megakaryocytes in suspension were
instead reduced, with only 1.861.0% of patient megakaryocytes
extending proplatelets vs 7.762.2% of controls after 16 hours
(p,0.05) (Figure 1B), but with a normal morphology. Defective
proplatelet formation was confirmed in experiments with a longer
incubation time (24 hours) (data not shown).
On the contrary, when megakaryocytes were plated on
fibrinogen proplatelets were numerically comparable to those of
controls (7.763.2% vs 6.760.4% n=3, p=ns), but presented
important structural alterations, with megakaryocytes showing a
spread shape, shorter proplatelet shafts and tips significantly
decreased in number and larger in size than those of controls
(Figure 1C, 1D and 1E). Interestingly, while pro-platelet
formation usually starts from one pole of the megakaryocyte and
rapidly leads to the conversion of the entire cytoplasm into
proplatelets [2], in our patients pro-platelet formation started at
multiple poles of the megakaryocyte cell body (Figure 1E, right).
Finally, proplatelet formation from patient’s megakaryocytes
incubated with type I collagen or Von Willebrand factor was
not different from that of control megakaryocytes [10–12] (on type
I collagen: 0.160.2% vs 0.160.2%, p=ns; on VWF 3.060.6% vs
3.860.2%, p=ns) (Figure 1B).
Megakaryocyte spreading
Megakaryocyte spreading on type I collagen was similar in
patients and controls (15.4% vs 18.663.3% of the total adhering
population, p=ns) as well as spreading on Von Willebrand factor
(5.2%vs5.961.3%ofthetotaladheringpopulation,p=ns).Onthe
contrary, spreading on fibrinogen was increased: 31.765.6% of the
total population of adhering megakaryocytes compared to 1062%
of controls (p,0.05). Two different populations were detectable
among patient megakaryocytes: one spreading normally (56.4
611% of the total spread population), and the other abnormally
(43.5611% of the total spread population) (Figure 2A).
Abnormally spread megakaryocytes showed nuclei displaced
towards cell periphery, a disordered distribution of actin and focal
adhesion points more evident than stress fibres (Figure 2B lower
panels).Normallyspreadmegakaryocytes,instead,showedcentral
nuclei and an ordered organization of actin in stress fibres and focal
adhesion points, similar to controls (Figure 2B upper panels).
aIIbb3 expression and activation
Integrin aIIbb3 was significantly less expressed on the surface of
patients’ megakaryocytes than on that of control megakaryocytes
(mean fluorescence intensity: 13.262.1 vs 21.562.2%, respective-
ly, p,0.05) (Figure 2C), in accordance with what we previously
observed with the patients’ platelets [7].
As b3 integrin is also a subunit of the aVb3 receptor (CD51/61),
we measured aVb3 by flow cytometry and we found that its
expression was comparable between patients and controls, both in
platelets (patients 4.860.6% vs controls 4.860.4%, p=ns) and in
megakaryocytes (patients 1361.1% vs controls 10.761.6%, p=ns)
(data not shown).
To study aIIbb3 receptor activation we measured the binding of
PAC-1, a monoclonal antibody that binds only to activated aIIbb3,
to un-stimulated megakaryocytes: 29.560.9% of patients’ mega-
karyocytes bound PAC1 vs 16.763.6% of control megakaryocytes
(Figure 3A), showing constitutive activation of aIIbb3 integrin in
patients’ megakaryocytes.
We therefore assessed aIIbb3-triggered outside-in signalling by
measuring the phosphorylation of FAK and Src after adhesion to
fibrinogen by western blotting [13].
Src and FAK were phosphorylated in patients’ megakaryocytes
also in suspension while in controls phosphorylation was observed
only upon adhesion to fibrinogen (Figure 3B).
We also assessed FAK clustering at immunofluorescence:
clustering was clearly evident in patients’ megakaryocytes already
one hour after plating on fibrinogen (Figure 3C right panel),
while with control megakaryocytes it was evident only after
3 hours. Moreover, FAK clusters were observed in patients’
megakaryocytes in suspension, differently from controls were they
were evident only upon contact with fibrinogen (Figure 3C left
panel), consistently with constitutive activation of aIIbb3.
Conversion of preplatelets into platelets
Very recently a new intermediate form between proplatelets
and platelets, the preplatelet, was described [3]. A preplatelet can
reversibly convert into a barbell-shaped proplatelet and generate
two platelets passing through a ‘‘figure 8’’ structure. We therefore
counted ‘‘figure 8’’ structures in platelet rich plasma (PRP) and we
observed a significantly lower percentage of them in patients’ PRP
as compared to controls (0.560.7% vs 2.161.2% respectively,
p,0.05) (Figure 4).
Discussion
Extracellular proteins play an important role in megakaryopoi-
esis and platelet formation by interacting with their receptors on
megakaryocytes [5]. In particular, the vascular niche is enriched in
fibrinogen and von Willebrand factor which drive the late phases
of megakaryopoiesis and allow proplatelet formation and platelet
release [4,5].
Here we show that two patients with a variant form of
Glanzmann Thrombasthenia (GT) associated with macrothrom-
bocytopenia, which is not normally present in GT, due to a partial
deletion of integrin b3 [7] have megakaryocytes that, despite
normal differentiation, fail to extend proplatelets in suspension,
form abnormal proplatelets on fibrinogen, and show reduced
preplatelet maturation.
Patient megakaryocytes expressed significantly less aIIbb3 on
their surface, as already seen with platelets [7], but this was
constitutively activated, as shown by PAC-1 binding under resting
conditions, by faster spreading upon contact with fibrinogen and
by FAK clustering and Src and FAK phosphorylation in
suspension. A constitutively activated aIIbb3 in our patient
megakaryocytes is consistent with a deletion involving the bTD,
a portion of aIIbb3 with a key role in maintaining the receptor in its
low affinity conformation, [8] and with our previous observation
that CHO cells expressing the b3 del647-686 mutation bind
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Giannini S, Corazzi T, Appolloni V, et al. (2010) Impact of a
novel integrin b3 mutation (del647-686), associated with a
Glanzmann’s variant hereditary platelet defect, on GPIIb/IIIa
expression and signalling. Blood Transfus 8: OC067].
The expression of aVb3, the receptor for vitronectin, was instead
normal probably due to the structural differences between aIIb and
aV in their calf2 domains [8,14], the domain interacting with bTD.
Spreading on fibrinogen showed a peculiar pattern, with half of
the population spreading normally, and half showing abnormal
spreading, similar to patients’ platelets [7] suggesting that a
preferential segregation of the mutant b3 subunits in clusters occurs
in some cells but not in others upon ligand binding to aIIbb3 [15].
Megakaryocyte spreading and proplatelet formation on Von
Willebrand Factor (VWF) were instead normal, which may be
unexpected because VWF is a ligand for aIIbb3. Given that in
platelets [16] and in aIIbb3 expressing CHO cells [17] the aIIbb3-
VWF interaction occurs only after integrin activation and that
signalling through GPIb-IX-V activates aIIbb3 [18], it is
conceivable that in megakaryocytes contact with VWF GPIb-IX-
V activates aIIbb3 that, in turn, promotes spreading. If this were
the case, in our patients a constitutively activated aIIbb3 would not
perturb VWF-mediated megakaryocyte spreading while it would
affect fibrinogen-mediated spreading, where this activation is not
required.
Also proplatelet formation on fibrinogen was abnormal in our
patients, with a reduced number of proplatelets with enlarged tips,
Figure 1. Megakaryocyte differentiation and proplatelet formation. (A) Megakaryocyte maturation stages of patients did not differ from
those of controls. (B) Proplatelet formation (PPF) from patient megakaryocytes in suspension was drastically reduced. When megakaryocytes were
plated on type I collagen proplatelet formation was absent, similar to controls, while on fibrinogen and von Willebrand factor the number of
megakaryocytes extending proplatelets was normal. *p,0.05 vs control. (C) Representative pictures of proplatelet formation in suspension, in a
control subject and a patient (206magnification). Arrows indicate pro-platelets, only one developing proplatelet is evident in the patient sample. (D,
E) Patient megakaryocytes extended a reduced number of proplatelets with abnormal characteristics: a spread shape with shorter than normal
proplatelet shafts and tips significantly decreased in number and larger in size than those of controls. *p,0.05 vs control. (F) Representative images
of megakaryocytes from patients and controls releasing proplatelets upon adhesion to fibrinogen.
doi:10.1371/journal.pone.0034449.g001
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of-function mutations of aIIbb3 associated with thrombocytopenia,
one at the cytoplasmic tail of b3 [19] and the second at the
cytoplasmic domain of aIIb [20]. Differently from these reports,
that demonstrated constitutive aIIbb3 activation only in cells
transfected with the mutant integrin [19,20], our study shows for
the first time a constitutively activated aIIbb3 in patients’
megakaryocytes. Altogether these observations show that an
absent aIIbb3 is less disruptive to thrombopoiesis than a hyper-
active receptor, suggesting that outside-in signalling must be
‘‘switched off’’ during platelet production.
Figure 2. Megakaryocyte spreading on fibrinogen and aIIbb3 expression. (A) and (B) When plated on fibrinogen two populations of
megakaryocytes are visible: half of the population spread regularly, while half showed abnormal spreading, with nuclei displayed towards cell
periphery, a disordered distribution of actin and focal adhesion points more evident than stress fibres. (C) Flow cytometry showed decreased
expression of aIIbb3 on the surface of patient’s megakaryocytes as compared with control megakaryocytes. *p,0.05 vs control.
doi:10.1371/journal.pone.0034449.g002
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phases of fibrinogen-induced proplatelet formation. In fact, ligand-
binding to aIIbb3 induces the activation of c-Src, normally
associated with the cytoplasmic tail of b3 in resting megakaryo-
cytes, and then FAK activation that in turn stimulates actin
remodelling leading to cell spreading [21]. A constitutively
activated FAK-Src signalling, as observed in our patients’
megakaryocytes, leads to permanent actin polymerization and
Figure 3. Integrin aIIbb3 activation and outside-in signalling. (A) Flow cytometry analysis of PAC-1 binding to resting megakaryocytes is
significantly increased in patients as compared with controls. *p,0.05 vs control. (B) Western blotting showed Src and FAK phosphorylation in
patient megakaryocytes in suspension as well as after adhesion onto fibrinogen. (C) Differently from control cells (upper panels), patient
megakaryocytes showed FAK clustering already after 1 hour of adhesion onto fibrinogen, and also in suspension (lower panels).
doi:10.1371/journal.pone.0034449.g003
Figure 4. Conversion of preplatelets into mature platelets. In patient’s peripheral blood less ‘‘figure 8’’ shapes are present. Two ‘‘figure 8’’
shapes are circled in white in control blood (left), while no ‘‘figure 8’’ shapes are visible in this picture of patient peripheral blood (right). Arrows show
examples of preplatelets.
doi:10.1371/journal.pone.0034449.g004
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treatment of megakaryocytes with an inhibitor of actin assembly,
cytochalasin [22], or by macrothrombocytopenia in mice
genetically deficient of ADF or cofilin, two proteins involved in
actin depolymerization [23].
Recently it has been shown that in the late maturation steps
leading to the formation of platelets, a malleable cytoplasm is
essential for the passage from preplatelets, large, oval-shaped
circulating platelet precursors, into barbell-shapes, by the twisting
of their microtubule cytoskeleton around their centre to yield
‘‘figure 8’’ structures, and finally into two individual platelets [3].
It is therefore conceivable that a rigid, constitutively activated
actin network may hinder proplatelet formation and lead to the
formation of platelets of an abnormal size, compatible with the
reduced maturation of preplatelets into platelets observed in our
patients’ blood.
In conclusion, impaired proplatelet formation from megakar-
yocytes, together with a normal number of reticulated platelets
excluding enhanced platelet destruction, lead us to conclude that
macrothrombocytopenia in our patients is due to defective platelet
formation. Our results show that constitutive activation of aIIbb3-
mediated outside-in signalling in human megakaryocytes nega-
tively influences proplatelet formation and open new perspectives
in the study of the role of the aIIbb3–fibrinogen axis in platelet
formation and related diseases.
Materials and Methods
Cell culture and immunofluorescence
CD45+ cells were separated from peripheral blood of the
patients and healthy controls and cultured as previously described
[5,11,24].
All subjects gave written informed consent to the study, which
was approved by the Committee on Bioethics of the University of
Perugia.
Megakaryocyte differentiation was evaluated at day 14 of
culture on cells (1610
5) cytospun on poly-L-lysine-coated glass
coverslips (Sigma-Aldrich, Milan, Italy) and stained with an anti
CD41 antibody or with May Grunwald Giemsa, as previously
described [10,25]. CD41 positive cells were classified according to
dimensions and nuclear configuration.
To evaluate proplatelet formation and megakaryocyte spreading
onto adhesive substrates megakaryocytes at day 14 of culture were
separated on a BSA gradient (3–4%), plated onto glass coverslips
coated with 100 mg/ml human fibrinogen (Sigma-Aldrich, St.
Louis, MO, USA), 10 mg/ml VWF-rich concentrate (Haemate P;
Aventis-Behring, Milan, Italy) or 25 mg/ml type I collagen from
bovine tendon (kind gift of prof M.E. Tira, University of Pavia) in
24-well plates (1610
5 cells per well), and allowed to adhere for 16 h
at 37uC and 5% CO2. To evaluate proplatelet formation in
suspension, megakaryocytes were seeded in 24 well plates and
incubated for 16 h at 37uC and 5% CO2.
Samples were then analyzed by immunofluorescence as
previously described [5]. Analysis was performed on 20 different
fields for each sample. For tips diameter and number measure-
ments, at least one hundred tips per sample were measured.
Proplatelet formation and megakaryocyte spreading onto differ-
ent substrates were calculated as the percentage of proplatelets or
spread megakaryocytes over the total megakaryocyte population
adhering to the substrate. Normal and abnormal spreading on
fibrinogen are expressed as the percentage of normal or abnormal
shapes out of the total population of spreading megakaryocytes.
FAK phosphorylation by immunofluorescence was assessed on
megakaryocytes plated for 1 hour onto fibrinogen or poly-L-lysine
using an anti phospho-FAK (Tyr 397) antibody (Cell Signalling,
Danvers, MA, USA).
Flow cytometry
CD41 expression was analyzed by flow cytometry after
incubation of Mks for 30 minutes with the FITC-conjugated
mAb anti-CD41 clone P2 (Beckman Coulter, Miami, FL, USA).
CD51 expression was analyzed incubating Mks and platelets for
30 minutes with a FITC-conjugated anti-CD51 mAb (Immuno-
tech, Marseille, France). To measure aIIbb3 activation Mks were
incubated for 30 minutes with the PAC-1 FITC mAb (BD
Biosciences, Milan, Italy), that recognizes activated aIIbb3. PAC-
1 binding is expressed as the percentage of megakaryocytes that
bind PAC-1 out of the total number of CD41-expressing cells.
For every mAb an isotypic antibody was used as a negative
control. Samples were analysed in an EPICS XL-MCL flow
cytometer (Beckman Coulter, Miami, FL, USA), equipped with an
argon laser operating at 488 nm [26].
SDS page and Western Blotting
Patient and control megakaryocytes were plated for 3 h at 37uC
on 12-well plates pre-coated with 100 mg/ml of purified human
fibrinogen or 1% BSA. Cells were then washed twice with PBS
and lysed with lysis buffer (40 mM Tris- HCl, 0.3 M NaCl, 1 mM
EDTA, 1 mM NaF, 1 mM Na3VO4,1 0 ml NP-40, 10 mg/ml
leupetin/pepstatin).
An equal amount of proteins were resolved by 8% SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred onto
nitrocellulose. Membranes were probed with a rabbit anti-
phospho–FAK (Tyr 397) or an anti-FAK MoAb, with a rabbit
anti-phospho-Src (Tyr416) or an anti-Src (Cell Signalling
Technology, Danvers, MA) MoAb and immunoreactive bands
were detected using peroxidase-conjugated secondary antibodies
and chemiluminescence detection.
Preplatelet ‘‘figure 8’’ counting
Patientandcontrolbloodwascentrifugedat100 gfor20 minutes
to obtain PRP; 10
6 platelets were then cytospun on poly-L-lysine-
coated glass coverslips (Sigma-Aldrich, St. Louis, MO, USA), fixed
with4%PFAfor 20minutes,permeabilizedwith0.1%Triton-Xfor
5 minutes, blocked with 3% BSA for 2 hours, stained with an anti-
b1 tubulin antibody(a kind gift of professor Joseph Italiano, Boston,
USA) and then with a secondary antibody conjugated with Alexa
Fluor 488 (Invitrogen, Life Technologies, Grand Island, NY, USA).
Specimens were mounted in Mowiol (Calbiochem, Merck,
Darmstadt, Germany) and analyzed through a Carl Zeiss Axio
Observer. A1 fluorescence microscope, using a 100X/1,4 Plan-
Apochromat oil-immersion objective.
‘‘Figure 8’’ preplatelets were counted as the percentage of
‘‘figure 8’’ shapes over the total number of b1 tubulin-positive
elements plated on the slide; the analysis was performed on 20
different fields for each sample.
Statistic analysis
Data are presented as means 6 SD. T test for unpaired data or
two way ANOVA were used to analyze data, with a significant
difference set at p,0.05.
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